vs
iSpecimen Inc.（ISPC）与MAXCYTE, INC.（MXCT）财务数据对比。点击上方公司名可切换其他公司
MAXCYTE, INC.的季度营收约是iSpecimen Inc.的92.5倍（$4.8M vs $51.8K）。MAXCYTE, INC.净利率更高（-200.5% vs -9662.2%，领先9461.7%）。MAXCYTE, INC.同比增速更快（-20.9% vs -96.5%）。过去两年MAXCYTE, INC.的营收复合增速更高（-7.4% vs -85.0%）
Specimen Products是一家总部位于芝加哥的乐器与音响设备制造商，由制琴师伊恩·施纳勒创立，主打定制吉他、电子管功放与号角音箱产品。品牌还依托旗下芝加哥吉他制作学院开设吉他、电子管功放的设计、制作与维修课程，工坊也面向公众提供设备维修服务，可调用稀有 vintage 厂商的零件储备开展维修。
MaxCyte Inc.是一家全球化生物技术企业，专注于开发细胞工程平台及细胞与基因治疗领域的赋能技术。其专利非病毒细胞修饰系统被制药、生物技术及生命科学研究机构广泛采用，支持免疫疗法、基因编辑疗法及下一代生物药从临床前到商业化的全流程研发。
ISPC vs MXCT — 直观对比
营收规模更大
MXCT
是对方的92.5倍
$51.8K
营收增速更快
MXCT
高出75.6%
-96.5%
净利率更高
MXCT
高出9461.7%
-9662.2%
两年增速更快
MXCT
近两年复合增速
-85.0%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $51.8K | $4.8M |
| 净利润 | $-5.0M | $-9.6M |
| 毛利率 | -964.4% | — |
| 营业利润率 | -5192.9% | -234.5% |
| 净利率 | -9662.2% | -200.5% |
| 营收同比 | -96.5% | -20.9% |
| 净利润同比 | 17.3% | 9.4% |
| 每股收益（稀释后） | $-0.67 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ISPCMXCT
| Q4 25 | $51.8K | $4.8M | ||
| Q3 25 | $106.6K | $4.6M | ||
| Q2 25 | $713.1K | $5.8M | ||
| Q1 25 | $1.1M | $5.7M | ||
| Q4 24 | $1.5M | $6.1M | ||
| Q3 24 | $2.7M | $5.6M | ||
| Q2 24 | $2.9M | $5.0M | ||
| Q1 24 | $2.3M | $5.6M |
净利润ISPCMXCT
| Q4 25 | $-5.0M | $-9.6M | ||
| Q3 25 | $-2.8M | $-12.4M | ||
| Q2 25 | $-1.0M | $-12.4M | ||
| Q1 25 | $-1.7M | $-10.3M | ||
| Q4 24 | $-6.0M | $-10.6M | ||
| Q3 24 | $-1.4M | $-11.6M | ||
| Q2 24 | $-2.1M | $-9.4M | ||
| Q1 24 | $-2.9M | $-9.5M |
毛利率ISPCMXCT
| Q4 25 | -964.4% | — | ||
| Q3 25 | -47.0% | — | ||
| Q2 25 | 44.4% | — | ||
| Q1 25 | 42.4% | — | ||
| Q4 24 | 13.5% | — | ||
| Q3 24 | 43.4% | — | ||
| Q2 24 | 51.9% | — | ||
| Q1 24 | 58.4% | — |
营业利润率ISPCMXCT
| Q4 25 | -5192.9% | -234.5% | ||
| Q3 25 | -2655.2% | -307.4% | ||
| Q2 25 | -255.4% | -244.3% | ||
| Q1 25 | -154.9% | -214.1% | ||
| Q4 24 | -395.8% | -213.1% | ||
| Q3 24 | -64.1% | -250.4% | ||
| Q2 24 | -76.2% | -241.0% | ||
| Q1 24 | -131.0% | -219.8% |
净利率ISPCMXCT
| Q4 25 | -9662.2% | -200.5% | ||
| Q3 25 | -2608.7% | -269.7% | ||
| Q2 25 | -146.9% | -212.2% | ||
| Q1 25 | -156.8% | -178.7% | ||
| Q4 24 | -409.8% | -175.0% | ||
| Q3 24 | -54.1% | -205.9% | ||
| Q2 24 | -73.6% | -188.8% | ||
| Q1 24 | -126.7% | -170.6% |
每股收益（稀释后）ISPCMXCT
| Q4 25 | $-0.67 | — | ||
| Q3 25 | $-0.48 | $-0.12 | ||
| Q2 25 | $-0.42 | $-0.12 | ||
| Q1 25 | $-0.71 | — | ||
| Q4 24 | $-5.40 | — | ||
| Q3 24 | $-2.10 | $-0.11 | ||
| Q2 24 | $-3.72 | $-0.09 | ||
| Q1 24 | $-6.36 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.9M | $103.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $3.1M | $171.5M |
| 总资产 | $9.5M | $202.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ISPCMXCT
| Q4 25 | $6.9M | $103.0M | ||
| Q3 25 | — | $105.7M | ||
| Q2 25 | — | $126.6M | ||
| Q1 25 | — | $138.3M | ||
| Q4 24 | $1.9M | $154.5M | ||
| Q3 24 | $1.8M | $153.8M | ||
| Q2 24 | $2.2M | $157.3M | ||
| Q1 24 | $2.1M | $157.5M |
股东权益ISPCMXCT
| Q4 25 | $3.1M | $171.5M | ||
| Q3 25 | $3.1M | $180.3M | ||
| Q2 25 | $622.0K | $190.7M | ||
| Q1 25 | $1.7M | $199.4M | ||
| Q4 24 | $3.3M | $206.3M | ||
| Q3 24 | $4.7M | $213.3M | ||
| Q2 24 | $6.1M | $221.3M | ||
| Q1 24 | $6.8M | $226.4M |
总资产ISPCMXCT
| Q4 25 | $9.5M | $202.5M | ||
| Q3 25 | $9.0M | $213.5M | ||
| Q2 25 | $6.0M | $219.8M | ||
| Q1 25 | $6.8M | $230.0M | ||
| Q4 24 | $9.4M | $239.5M | ||
| Q3 24 | $11.3M | $248.6M | ||
| Q2 24 | $11.9M | $251.5M | ||
| Q1 24 | $12.5M | $257.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-916.9K | $-2.7M |
| 自由现金流经营现金流 - 资本支出 | — | $-2.9M |
| 自由现金流率自由现金流/营收 | — | -61.0% |
| 资本支出强度资本支出/营收 | — | 4.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-36.2M |
8季度趋势，按日历期对齐
经营现金流ISPCMXCT
| Q4 25 | $-916.9K | $-2.7M | ||
| Q3 25 | $-2.0M | $-7.5M | ||
| Q2 25 | $-192.2K | $-9.9M | ||
| Q1 25 | $-1.1M | $-14.4M | ||
| Q4 24 | $-3.6M | $-7.8M | ||
| Q3 24 | $-1.1M | $-4.4M | ||
| Q2 24 | $-1.5M | $-4.8M | ||
| Q1 24 | $-2.1M | $-10.6M |
自由现金流ISPCMXCT
| Q4 25 | — | $-2.9M | ||
| Q3 25 | — | $-7.8M | ||
| Q2 25 | — | $-10.4M | ||
| Q1 25 | — | $-15.1M | ||
| Q4 24 | $-3.6M | $-8.0M | ||
| Q3 24 | $-1.1M | $-4.8M | ||
| Q2 24 | — | $-5.1M | ||
| Q1 24 | $-2.1M | $-11.4M |
自由现金流率ISPCMXCT
| Q4 25 | — | -61.0% | ||
| Q3 25 | — | -168.5% | ||
| Q2 25 | — | -179.2% | ||
| Q1 25 | — | -262.3% | ||
| Q4 24 | -242.7% | -131.6% | ||
| Q3 24 | -41.1% | -85.5% | ||
| Q2 24 | — | -103.3% | ||
| Q1 24 | -90.9% | -203.6% |
资本支出强度ISPCMXCT
| Q4 25 | — | 4.8% | ||
| Q3 25 | 0.0% | 6.5% | ||
| Q2 25 | — | 10.0% | ||
| Q1 25 | — | 11.4% | ||
| Q4 24 | 0.5% | 2.4% | ||
| Q3 24 | 0.5% | 7.2% | ||
| Q2 24 | 0.0% | 5.9% | ||
| Q1 24 | 0.4% | 14.4% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
